Furthermore, varying expression patterns of HMGB1 have been observed in patients with asthma, COPD, endometrial carcinoma, bladder cancer, and lung cancer, and the pathogenesis of all has been considered to be importantly related to EMT 42-44. Here, HMGB1 is linked to chronic obstructive pulmonary disease.